Pretax income is the income that a company earns before paying income taxes. Procyon's pretax income for the
three
months ended in Jun. 2024 was $0.03 Mil.
Its pretax income for the trailing twelve months (TTM) ended in Jun. 2024 was $-0.17 Mil.
Procyon's pretax margin was 1.77%.
During the past 13 years, Procyon's highest Pretax Margin was 15.55%. The lowest was -12.23%. And the median was 1.54%.
Procyon Pre-Tax Income Historical Data
The historical data trend for Procyon's Pre-Tax Income can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of Procyon's Pre-Tax Income
For the Drug Manufacturers - Specialty & Generic subindustry, Procyon's Pre-Tax Income, along with its competitors' market caps and Pre-Tax Income data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Procyon's Pre-Tax Income Distribution in the Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Procyon's Pre-Tax Income distribution charts can be found below:
* The bar in red indicates where Procyon's Pre-Tax Income falls into.
Pre-Tax Income for the trailing twelve months (TTM) ended in Jun. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $-0.17 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Procyon (OTCPK:PCYN) Pre-Tax Income Explanation
Procyon's Pretax Margin for the quarter that ended in Jun. 2024 is calculated as
During the past 13 years, Procyon's highest Pretax Margin was 15.55%. The lowest was -12.23%. And the median was 1.54%.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Procyon Pre-Tax Income Related Terms
Thank you for viewing the detailed overview of Procyon's Pre-Tax Income provided by GuruFocus.com. Please click on the following links to see related term pages.
Procyon Corp is a United-based company, through its subsidiary, it is engaged in developing and marketing proprietary medical products used to treat pressure ulcers, stasis ulcers, wounds, dermatitis, inflammation, and other skin problems. Its wound care products are sold through distributors to institutional customers such as hospitals, wound care clinics, skilled nursing facilities, home health agencies, and physicians and other healthcare practitioners. The firm's product lines are AMERX, AMERIGEL, and HELIX3 Bioactive Collagen. The skin and wound care products are marketed under the trademark AMERIGEL which contains the proprietary ingredient OAKIN which promotes wound healing and healthy skin. The corporation markets its products in the United States.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
PCYN has been successfully added to your 